JHVEPhoto Since I initiated coverage on October 20, 2023, Abbott Laboratories' (NYSE:ABT) stock price has risen by 16.6%, compared to the index return of 14.2%. I highlighted their robust and innovative product pipeline in the introductory article. I believe the company is successfully overcoming challenges related to the COVID-19 pandemic, and I reiterate a 'Strong Buy' rating with a fair value of $115 per share. Recent Result and FY24 Outlook In Q4 FY23, Abbott Laboratories achieved 2.1% organic revenue g ...